Ethnic Disparities in Access to Genetic Testing Impact Prostate Cancer Treatment, Research Shows
Two new studies emphasize the need for ethnically diverse prostate cancer genomics data and accessible genetic testing.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Prostate |
Two new studies emphasize the need for ethnically diverse prostate cancer genomics data and accessible genetic testing.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Prostate |
VA medical centers with low prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Prostate |
P4 Diagnostix and Pierian will be launching somatic testing for prostate cancer patients, expanding P4’s Urology NGS Services.
Read MorePosted by Andy Lundin | Sep 23, 2022 | Prostate |
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Read MorePosted by Andy Lundin | Aug 19, 2022 | Prostate |
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice.
Read More